Sec. 737. Prohibition on availability of funds for research connected to China
212 words·~1 min read·
/bill/117/hr/4350/pcs/section-737·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
None of the funds authorized to be appropriated by this Act or otherwise made available for fiscal year 2022 for the Department of Defense may be obligated or expended— to conduct research in China, including biomedical, infectious disease, gene editing, genetics, virus, or military medical research, whether directly or through a third-party entity; or to provide funds for research, including biomedical, infectious disease, gene editing, genetics, virus, or military medical research, to any entity determined by the Secretary of Defense to be owned or controlled, directly or indirectly, by China. The Secretary of Defense may waive a prohibition under subsection
(a)if the Secretary— determines that the waiver is in the national security interests of United States; and not later than 14 days after granting the waiver, submits to the congressional defense committees a detailed justification for the waiver, including— an identification of the Department of Defense entity obligating or expending the funds; an identification of the amount of such funds; an identification of the intended purpose of such funds; an identification of the recipient or prospective recipient of such funds (including any third-party entity recipient, as applicable); an explanation for how the waiver is in the national security interests of the United States; and any other information the Secretary determines appropriate.